Portola Pharmaceuticals
PTLA
#5420
Rank
$1.41 B
Marketcap
$18.03
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Portola Pharmaceuticals (PTLA)

Revenue in 2020 (TTM): $0.12 Billion USD

According to Portola Pharmaceuticals 's latest financial reports the company's current revenue is $0.12 Billion USD. In 2019 the company made a revenue of $0.11 Billion USD an increase over the revenue in the year 2018 that were of $40.13 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Portola Pharmaceuticals from 2012 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)$0.12 B3.62%
2019$0.11 B190.66%
2018$40.13 M77.99%
2017$22.54 M-36.5%
2016$35.5 M194.15%
2015$12.07 M25.39%
2014$9.62 M-8.6%
2013$10.53 M-85.38%
2012$72.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
$92.14 B 76,144.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$62.78 B 51,849.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$47.52 B 39,222.42%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$10.06 B 8,228.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$48.03 B 39,643.50%๐Ÿ‡บ๐Ÿ‡ธ USA